SCHEMBL31661720

SCHEMBL31661720

O=C(c1ccccc1Br)N1CCOCC1

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.67
▸ LMNA P02545 1/20 0.67
▸ GAA P10253 2/20 0.62
▸ SMN1; SMN2 Q16637 1/20 0.62
▸ RAB9A P51151 1/20 0.61
▸ MAPT P10636 2/20 0.58
▸ KMT2A Q03164 2/20 0.58
▸ L3MBTL3 Q96JM7 1/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ TSHR P16473 1/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.56
▸ TP53 P04637 1/20 0.56
▸ CNR1 P21554 1/20 0.56
▸ MEN1 O00255 1/20 0.55
▸ ERN1 O75460 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1663182 1.00 ALDH1A1 (0.67) ALDH1A1LMNAGAASMN1; SMN2RAB9A
SCHEMBL7121916 0.87 SMN1; SMN2 (0.77) ALDH1A1GAASMN1; SMN2KMT2ATSHR
SCHEMBL11722321 0.87 ALDH1A1 (0.77) ALDH1A1LMNAGAASMN1; SMN2MAPT
SCHEMBL29486100 0.84 GAA (0.52) ALDH1A1LMNAGAASMN1; SMN2RAB9A
SCHEMBL2376795 0.84 HPGD (0.53) ALDH1A1LMNAGAASMN1; SMN2RAB9A
SCHEMBL28746378 0.84 GAA (0.52) ALDH1A1LMNAGAASMN1; SMN2RAB9A
SCHEMBL2375485 0.84 ALDH1A1 (0.55) ALDH1A1LMNAGAASMN1; SMN2RAB9A
SCHEMBL4163170 0.84 L3MBTL3 (0.71) ALDH1A1LMNAGAASMN1; SMN2RAB9A
SCHEMBL3455048 0.82 L3MBTL3 (0.69) ALDH1A1LMNAGAASMN1; SMN2RAB9A
SCHEMBL19357117 0.81 PHGDH (0.63) ALDH1A1LMNAGAASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 — — WO claimed
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 — — WO disclosed
Send feedback